"According to the requirements of the State Medical Insurance Bureau", Guangyao's large -scale withdrawal from the Internet in many provinces, or improper gains involved

In June, the old pharmaceutical company Guangyao Baiyun Mountain was undergoing an earthquake: Within a few days, hundreds of medicines in Baiyun Mountain in Guangyao were withdrawn from the Internet in many provinces.

Such a large scale and scope are rare.

On June 14, the Shanxi side released news: Many subsidiaries of Baiyunshan took the initiative to apply for a cancellation of 89 pharmaceutical regulations for procurement qualifications in Shanxi, and at the same time adjusted some drug prices of some networks. According to the Shanxi Provincial Pharmaceutical Institute of Pharmaceuticals, the product cannot be hung up within two years of withdrawal. Immediately afterwards, Shanxi issued a notice on June 15 to adjust the drug hanging price of the two other companies under Guangyao.

Picture source: Shanxi Provincial Pharmaceutical and Devices Bidding Purchasing Network

On June 10, the Anhui Medical Concentrated Procurement Service Center also issued the "Announcement on Part of the Pharmaceuticals and Price Rectification of Baiyunshan". The wording in the article is even more intense.

According to Anhui, in accordance with the requirements of the National Medical Insurance Bureau, the relevant drugs of many subsidiaries under Baiyunshan were withdrawn and rectified the price. Bai Yunshan appealed. However, Anhui issued the "Announcement on the Rectification of Partial Drug Price Rectification of Baiyunshan Tianxin" on June 17, rejected Bai Yunshan's appeal.

In addition, Guizhou and Shandong provinces have also issued similar notices. On June 10, Guizhou announced that the information of related drugs related to 3 households of Guangyao Group's subsidiaries was adjusted to reduce prices or withdraw from the network for related drugs. The variety was withdrawn from the net.

What happened to Guangyao Baiyun Mountain?

Rumors in the industry show that Guangyao Group may involve serious commercial bribery incidents so that the State Medical Insurance Bureau requires.

The documents circulating in the industry may involve bribery

A internal document obtained by the Jianzhi Bureau shows that on April 22, 2022, the Guangdong Provincial Health and Health Commission issued a "Notice of the Office of the Guangdong Provincial Health and Health Commission on the adjustment of the basic medication supply directory of organizational medical institutions."

Picture source: Guangxi Province Health and Health Committee

The document shows: "On April 17, the Provincial Medical Insurance Bureau reported that the relevant drugs of two manufacturers under the Guangzhou Pharmaceutical Group of the Communist Party of China had the use of virtual high prices and promotion of unfair business means."

The large -scale withdrawal of the products of Guangyao may be related to this matter.

The above four provinces have different announcements on the announcement of Guangyao, and their expressions are different: Shanxi Province is "applying in accordance with the enterprise", Guizhou Province is "reported according to enterprises", Anhui Province is "according to the requirements of the National Medical Insurance Bureau", and Shandong Province is "discontinued in drugs to discontinue production Or duplicate products. "

The Shanxi Province notice showed that the enterprises actively withdrawn from the Internet were Guangzhou Baiyunshan Jingxiu Pharmaceutical, Baiyunshan Pharmaceutical General Factory, and Baiyunshan Tianxin Pharmaceutical. West Na Na Na (Kim Ge), cephalosporin ester tablets, cephalosporin sodium sodium sodium, clearing heat and anti -inflammatory capsules, etc. "Kim Ge" and other best -selling varieties of Baiyun Mountain.

The company that withdrew from Anhui is the same as Shanxi. 229 pharmaceutical products including amoxicillin and cephalosporin ester of the three companies in the Department of Pharmaceuticals have been revoked and price rectification. Among them, 152 drugs such as amoxicillin, cephalosporidine, and sodium in injection of cephalosporin are included in the disabled directory.

Guizhou "removed" Baiyunshan Pharmaceutical General Factory, Baiyunshan Tianxin Pharmaceutical's citrate citrate sinosaine (Jine), cephalosporin sink tablets, and cephalosporin sodium in injection. In addition, 43 pharmaceutical regulations such as amoxicillin and 西 Lesin sodium were required to reduce prices.

In some provinces, the varieties of the Department of Pharmaceutical applied for active price reductions.

On June 8, Liaoning said that "the application for the active price reduction of the enterprise" was greatly reduced to the price of ammonia sodium sodium in the injection of Baiyunshan Tianxin Pharmaceutical Pharmaceutical Pharmaceutical, and the two specifications were adjusted from 48 yuan and 17.8 yuan to 18.75 yuan and 9.9 yuan.

These provinces involve the same varieties of withdrawal and price reductions, which are the same as the drugs in the internal documents in Guangdong.

The above -mentioned Guangdong internal documents show that "there is a virtual high price and the use of unfair business means promotions", including 31 varieties of sodison phosphate injections in Guangzhou Baiyunshan Tianxin Pharmaceuticals and sold. Seven varieties of Bao Er'an Granules produced and sold in the Mountain Drugs General Plant.

According to the "Management Guidelines for the Basic Medicine Supply of Medical Institutions in Guangdong Province": Drugs that are used for clinical promotions using improper means, they should be eliminated from the basic medication supply directory of medical institutions.

Therefore, in the internal documents of Guangdong, it is pointed out: "The above two manufacturers related drugs are in line with medical institutions' basic drug supply directory elimination drug conditions." This may trigger the corresponding punishment of Guangyao Baiyun Mountain in other provinces.

Some people in the industry have speculated that the withdrawal from the net is related to the discounting and mining of Baiyun Mountain earlier this year.

In March 2022, Baiyunshan Tianxin Pharmaceutical was broken up by the Gansu Provincial Medical Insurance Bureau for the dismissal of the procurement agreement, the disqualification of the selection, and the withdrawal of the network.

Repeated violations, state -owned enterprises have no effect on rectification

"Jin Ge", amoxicillin, and cephalosporin sodium such as cephalosporin sodium are important varieties of Guangyao Baiyun Mountain.

Especially "Jin Ge", this anti -ED drug sales have surpassed Pfizer's "Wan Aike" in 2019, becoming the best male medicine in China. Within Guangyao Baiyun Mountain, "Jin Ge" is the largest heavy product in its revenue. In 2021, 98.498 million pieces were sold with sales revenue of 988 million yuan.

Citic acid Sidda has been included in the national collection, and the "Jin Ge" of Guangyao has failed to obtain a collection of collection and basically lost the hospital market. With the retail end, "Jin Ge" can achieve such sales performance, which is quite amazing. With the variety of Guangyao's withdrawal or lowering prices in many provinces, the hospital market will inevitably be impacted. A large number of prescription drugs cannot rely entirely on retail channels, and it is bound to face a decline in sales.

Strangely, as a state -owned enterprise in Guangzhou, Guangyao Group, this time, has appeared in many provinces.

In May 2021, Shanghai Sunshine Pharmaceutical Procurement Network issued the "Public Announcement on the Price Price Price of Pharmaceutical Protection in Shanghai in 2021" (Phase 1), and the non -citrus price of citronic acid in Baiyunshan Pharmaceutical General Factory is higher than that The lowest price of five provinces and cities.

In May 2021, in the bribery case of Li Xueting, a orthopedic hospital in Zhengzhou, in addition to the main business involved in the case of Fu Pharmaceutical, Guangyao Baiyun Mountain was also involved in it.

In June 2021, Yunnan Province monitored: Some companies including Baiyun Mountain cannot be supplied normally. Involved Entica, Atropine, etc.

In August 2021, the Hunan Provincial Public Resources Service Platform issued the "Notice on the results of the evaluation of the pharmaceutical price and recruitment credit rating of Hunan Province".

In August 2021, the Heilongjiang Provincial Medical Insurance Bureau disclosed that a pharmaceutical industry in Baiyun Mountain was withdrawn from the Internet. The reason for the withdrawal of the network was a number of costs rising. The winning bid price could not support normal production and operations, and it could not continue to ensure normal supply.

Under normal circumstances, the drug withdrawal network is mainly divided into two situations: active withdrawal and passive withdrawal. In addition to actively abandoning the internal market's active withdrawal network, the price linkage is not in place, suspected commercial bribery, recruitment of credit, misconduct, and trustworthiness. Prand interruptions and other behaviors may cause drugs to be withdrawn from the net.

"It is taken down" must mean that companies involve relatively serious bad behaviors. The typical case is the autumn of 2021. The North China Pharmaceuticals that have been canceled for three years because of the collection and breaking supply, and because of commercial bribes, they are rated as "serious dishonesty. "Yichang Renfu Pharmaceutical.

The Jianzhi Bureau repeatedly contacted Guangyao Baiyun Mountain, but as a large listed company, the company's secretary phone and the securities affairs department's telephone unable to connect or prompts the company's annual report.

The subsequent impact of the Guangzhou Pharmaceutical incident remains to be observed. If it is said in Anhui, it is the "National Medical Insurance Bureau request", in the future, more provinces may withdraw products from Guangyao Baiyunshan. Jianzhi Bureau continues to pay attention.

Writing ｜ Zhang Ling

Edit ｜ Jiang Yun Jia Ting

Figures ｜ Twenty -thirty

Operation | Twenty -thirty

### 药#

- END -